Michael Van Spall

Michael Van Spall is a medical doctor and project manager currently serving as a Global Safety Officer at Sanofi Genzyme, where they ensure global patient safety oversight of Dupixent. They previously held roles including Pharmacovigilance Manager at Servier and Drug Safety Physician at Labopharm, focusing on pharmacovigilance and medical information in various therapeutic areas. Michael studied medicine at Poznan University of Medical Sciences and holds a degree in English literature from Concordia University. With extensive experience in clinical studies and a bilingual proficiency in English and French, they excel in patient-centric drug safety and signal detection.